Tabula Rasa HealthCare Names April Gill Chief Commercial Officer

$TRHC
Business Services
Consumer Discretionary
Get the next $TRHC alert in real time by email

MOORESTOWN, N.J., Nov. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of April D. Gill as Chief Commercial Officer. Ms. Gill has more than 20 years of experience in healthcare with a proven track record exceeding client satisfaction, sales, and profitability goals.

In this newly created role, Ms. Gill will oversee development and execution of TRHC's commercialization with broad responsibility for strategy, product, marketing, communications, sales, and account management activities.

"April is an accomplished executive with a wealth of healthcare expertise focused on commercialization efforts, client success, and business strategies to drive growth," said Brian Adams, President and Interim CEO of TRHC. "I am thrilled to welcome April to TRHC and look forward to working with her and the entire team as we advance our go-to-market strategy to take advantage of existing and emerging opportunities adjacent to our core PACE market."

Previously, Ms. Gill was EVP & General Manager Health Plans & Health Systems for Virgin Pulse (formerly Welltok) where she led development of value-based products, software, and services for the health plan and health system markets. Prior to that, she was Chief Strategy Officer & SVP Solution Management for Welltok with a focus on execution of strategic initiatives and leading a cross-functional team responsible for product, marketing, sales, and consumer experience.

"I am excited to join Tabula Rasa at this pivotal time in its history," said April Gill. "I am encouraged by TRHC's strong foundation and am looking forward to building a robust commercial organization to accelerate growth and advance the development of industry leading products and services for value-based markets."

About Tabula Rasa HealthCare

Tabula Rasa HealthCare (TRHC) (NASDAQ:TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combating medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC's proprietary technology solutions, including MedWise®, improve patient outcomes and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and at-risk provider groups to help drive value-based care. For more information, visit tabularasahealthcare.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tabula-rasa-healthcare-names-april-gill-chief-commercial-officer-301663577.html

SOURCE Tabula Rasa HealthCare, Inc.

Get the next $TRHC alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TRHC

DatePrice TargetRatingAnalyst
5/10/2023$7.00 → $10.00Market Perform → Outperform
SVB Securities
3/2/2022$30.00 → $15.00Buy
Benchmark
2/28/2022$23.00 → $11.00Market Perform
SVB Leerink
2/1/2022$24.00 → $11.00Outperform → Neutral
Robert W. Baird
2/1/2022$24.00 → $11.00Outperform → Neutral
Baird
12/2/2021$13.00Hold
Jefferies
11/8/2021$70.00 → $23.00Outperform
RBC Capital
11/8/2021$40.00 → $23.00Market Perform
SVB Leerink
More analyst ratings

$TRHC
Press Releases

Fastest customizable press release news feed in the world

See more
  • Lifshitz Law PLLC Announces Investigations of VRTV, FRGI, TRHC, and SOVO

    NEW YORK, Aug. 12, 2023 (GLOBE NEWSWIRE) -- Veritiv Corporation (NYSE:VRTV) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of VRTV to an affiliate of Clayton, Dubilier & Rice, LCC for $170.00 per share in cash for each share of VRTV common stock owned. If you are a VRTV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com. Fiesta Restaurant Group, Inc. (NASDAQ:FRGI) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary dutie

    $FRGI
    $SOVO
    $TRHC
    $VRTV
    Restaurants
    Consumer Discretionary
    Packaged Foods
    Consumer Staples
  • Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

    Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today reported financial results for the second quarter ended June 30, 2023. Highlights from the second quarter ended June 30, 2023 include: Second quarter revenue from continuing operations of $90.0 million

    $TRHC
    Business Services
    Consumer Discretionary
  • Tabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex Needs

    $10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with First of its Kind Risk Management Platform in Pharmacy Care Expands the Reach of Tabula Rasa's MedWise Technology Platform to Multiple Provider and Payer Markets MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC," "Tabula Rasa" or the "Company") (NASDAQ:TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today announced it has entered into a definitive agreement (the "Agreement") to be acquired by Nauti

    $TRHC
    Business Services
    Consumer Discretionary

$TRHC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$TRHC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$TRHC
SEC Filings

See more

$TRHC
Leadership Updates

Live Leadership Updates

See more
  • Tabula Rasa HealthCare Provides Corporate Updates

    Appoints Brian Adams as President and Chief Executive Officer and a Member of the Board of Directors, Effective Immediately Appoints Richard W. Rew II as Chief Legal Officer and Corporate Secretary Announces Preliminary Unaudited First Quarter 2023 Revenue Exceeding Guidance MOORESTOWN, N.J., April 13, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of Brian Adams as President and Chief Executive Officer. Mr. Adams, who was serving as TRHC's interim Chief Executive Officer since September 2022 and previously served as the Company's Co-Pre

    $TRHC
    Business Services
    Consumer Discretionary
  • Tabula Rasa HealthCare Names April Gill Chief Commercial Officer

    MOORESTOWN, N.J., Nov. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of April D. Gill as Chief Commercial Officer. Ms. Gill has more than 20 years of experience in healthcare with a proven track record exceeding client satisfaction, sales, and profitability goals. In this newly created role, Ms. Gill will oversee development and execution of TRHC's commercialization with broad responsibility for strategy, product, marketing, communication

    $TRHC
    Business Services
    Consumer Discretionary
  • Tabula Rasa HealthCare Announces Leadership Transition

    Drs. Calvin H. Knowlton and Orsula V. Knowlton to retire from the Company Co-President Brian Adams Named Interim CEO Director Michael Purcell Named Independent Board Chairman MOORESTOWN, N.J., Sept. 14, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that co-founders Dr. Calvin H. Knowlton, BScPharm, MDiv, PhD, ScD (hon), Chief Executive Officer and Board Chairman, and Dr. Orsula V. Knowlton, PharmD, MBA, Co-President and Chief Marketing and New Business Development Officer, will retire from TRHC and step down as members of the Board of Directors, effective immediately. Dir

    $TRHC
    Business Services
    Consumer Discretionary

$TRHC
Financials

Live finance-specific insights

See more
  • Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

    Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today reported financial results for the second quarter ended June 30, 2023. Highlights from the second quarter ended June 30, 2023 include: Second quarter revenue from continuing operations of $90.0 million

    $TRHC
    Business Services
    Consumer Discretionary
  • Tabula Rasa HealthCare Schedules Second Quarter 2023 Earnings Conference Call

    MOORESTOWN, N.J., July 25, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2023 financial results Tuesday, August 8, 2023 at 8:30 a.m. EDT. The Company's financial results for the second quarter 2023 ended June 30, 2023, will be released after the close of the market Monday, August 7, 2023. Those interested in participating via webcast in listen-only mode can access the event here. For participants who would like to participate via telephone, please register here to receive the dial-in numbe

    $TRHC
    Business Services
    Consumer Discretionary
  • Tabula Rasa HealthCare Reports First Quarter 2023 Financial Results

    First Quarter Results Show Benefits of Consistent Execution on Financial and Strategic Objectives First Quarter Revenue Growth of 32% Compared to First Quarter 2022 Raises Full Year 2023 Revenue and Adjusted EBITDA Guidance MOORESTOWN, N.J., May 8, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the first quarter ended March 31, 2023. Highlights from the first quarter ended March 31, 2023, include: First quarter revenu

    $TRHC
    Business Services
    Consumer Discretionary

$TRHC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more